Cleared Traditional

EVOL® ha-C Cervical Interbody Fusion System (K180674) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2018
Decision
102d
Days
Class 2
Risk

K180674 is an FDA 510(k) clearance for the EVOL® ha-C Cervical Interbody Fusion System. Classified as Intervertebral Fusion Device With Bone Graft, Cervical (product code ODP), Class II - Special Controls.

Submitted by Cutting Edge Spine, LLC (Waxhaw, US). The FDA issued a Cleared decision on June 25, 2018 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Cutting Edge Spine, LLC devices

Submission Details

510(k) Number K180674 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 15, 2018
Decision Date June 25, 2018
Days to Decision 102 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 122d · This submission: 102d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code ODP Intervertebral Fusion Device With Bone Graft, Cervical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - ODP Intervertebral Fusion Device With Bone Graft, Cervical

All 182
Devices cleared under the same product code (ODP) and FDA review panel - the closest regulatory comparables to K180674.
Tyber Medical PT Interbody Spacer System
K180590 · Tyber Medical, LLC · Jul 2018
HD LifeSciences Cervical IBFD System
K180364 · Hd Lifesciences, LLC · Jun 2018
MONET™ Anterior Cervical Interbody Fusion Cage System
K172788 · Ctl Medical Corporation · Jun 2018
TiWAVE-C™ Porous Titanium Cervical Cage
K180401 · Kalitec Direct, LLC · Jun 2018
Atlas Spine Expandable Cervical Interbody System
K180675 · Atlas Spine, Inc. · Jun 2018
PATRIOT COLONIAL Spacer, SUSTAIN Spacer
K173722 · Globus Medical, Inc. · May 2018